X4 Pharmaceuticals, Inc (XFOR) Retained Earnings (Accumulated Deficit) USD 2017 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
X4 Pharmaceuticals, Inc quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2017 to 2024.
  • X4 Pharmaceuticals, Inc Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$530 M, a 32.2% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$530 M -$129 M -32.2% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$478 M -$101 M -26.9% Dec 31, 2023 10-Q 2024-05-07
Q3 2023 -$459 M -$111 M -32% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$456 M -$130 M -40% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 -$401 M -$95.9 M -31.5% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$377 M -$93.9 M -33.2% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$348 M -$95 M -37.6% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$326 M -$93.6 M -40.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$305 M -$92 M -43.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$283 M -$88.7 M -45.7% Dec 31, 2021 10-K 2023-03-21
Q3 2021 -$253 M -$76.9 M -43.7% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$232 M -$74.2 M -46.8% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 -$213 M -$69.7 M -48.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$194 M -$62.1 M -47.1% Dec 31, 2020 10-K 2022-03-17
Q3 2020 -$176 M -$54.6 M -45% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$158 M -$54.8 M -53% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 -$143 M -$53.1 M -58.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$132 M -$52.8 M -66.6% Dec 31, 2019 10-K 2021-03-19
Q3 2019 -$121 M +$4.72 M +3.75% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 -$103 M +$11.5 M +10% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$90.1 M +$12.8 M +12.4% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 -$79.2 M +$13 M +14.1% Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$126 M Sep 30, 2018 10-Q 2018-11-09
Q2 2018 -$115 M Jun 30, 2018 10-Q 2018-08-13
Q1 2018 -$103 M Mar 31, 2018 10-Q 2018-05-10
Q4 2017 -$92.3 M Dec 31, 2017 10-K 2019-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.